← Open Payments lookup

MARK CHELTENHAM: Open Payments

NPI 1114027588 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$149 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $36 · 2025 $149

Food & beverage: $149
CompanyPaymentsAmount
Luye Pharma (USA) Ltd.2$46
Teva Pharmaceuticals USA, Inc.1$26
Otsuka America Pharmaceutical, Inc.1$25
ABBVIE INC.1$20
E.R. Squibb & Sons, L.L.C.1$18
Janssen Pharmaceuticals, Inc1$14

Products named: ERZOFRI EXTENDED-RELEASE, UZEDY, ABILIFY ASIMTUFII, VRAYLAR, COBENFY, INVEGA SUSTENNA.

Industry payments across NC — which companies pay providers there.